SCHEMBL4557598

SCHEMBL4557598

O=C1CN(c2ccc(CCNC(=O)c3ccc(F)cc3)cc2O)S(=O)(=O)N1.O=C1CN(c2ccc(CCNC(=O)c3ccccc3)cc2O)S(=O)(=O)N1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
NAMPT P43490 3/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
THRB P10828 1/20 0.45
MAPT P10636 3/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44
PTPN1 P18031 2/20 0.43
PARP1 P09874 1/20 0.42
MCHR1 Q99705 1/20 0.41
SIRT1 Q96EB6 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3213632 0.96 ALDH1A1 (0.47) NPC1RAB9ANAMPTALDH1A1LMNA
SCHEMBL3205299 0.94 MEN1 (0.48) RAB9ANAMPTALDH1A1MAPTMEN1
SCHEMBL3918932 0.91 NPC1 (0.47) NPC1RAB9ANAMPTALDH1A1LMNA
SCHEMBL2936685 0.87 NPC1 (0.43) NPC1RAB9ANAMPTALDH1A1LMNA
SCHEMBL4782790 0.84 MEN1 (0.42) NPC1RAB9ANAMPTMEN1GAA
SCHEMBL3224733 0.83 NPC1 (0.39) NPC1RAB9ANAMPTALDH1A1LMNA
SCHEMBL3759377 0.81 PTPN1 (0.46) NPC1RAB9ANAMPTMAPTMEN1
SCHEMBL3218066 0.80 KDM4E (0.52) ALDH1A1LMNAMAPTPTPN1SMN1; SMN2
SCHEMBL3915822 0.80 ABCB1 (0.43) RAB9ANAMPTALDH1A1LMNAMEN1
SCHEMBL3215930 0.79 PTPN1 (0.56) PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2089026-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE PROMOTION OF PHYSIOLOGICAL CARDIAC HYPERTROPHY Novartis AG (CH) 2009-08-19 EP disclosed
WO-2008070552-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE PROMOTION OF PHYSIOLOGICAL CARDIAC HYPERTROPHY NOVARTIS AG (CH) 2008-06-12 WO disclosed